In a more recent investigation, an MS-based proteomics workflow for identifying differentially abundant proteins in renal cell carcinoma (RCC) demonstrated elevated levels of enolase 2 (ENO2) and thrombospondin-1 (TSP1) in tumor TIF. Here, ENO2 is linked to renal cell carcinoma.